The report "Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028", size is projected to reach USD 8.2 billion by 2028 from 4.4 billion in 2023, at a CAGR of 13.4% during the forecast period. Factors such as rising cell based research and increasing focus on personalized medicine are driving the growth of this market. However, high cost and safety, ethical issues, are the major factors restraining the growth of this market.
Browse 412 market data Tables and 46 Figures spread through 307 Pages and in-depth TOC on "Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cell-isolation-market-103931479.html
The consumables segment accounted for the largest share of the product segment in the cell isolation market in 2022.
Based on product, the cell isolation market is broadly segmented into consumables, and instruments. In 2022, consumables accounted for the largest share of the cell isolation market for product. This segment's large share can be attributed to factors such as the wide usage of reagents during cell isolation and continuous introduction of advanced consumables for cell isolation. Consumables can be used for a wide range of applications and cell types, making them a versatile choice for researchers. Some consumables, such as antibody-based cell isolation kits, are non-destructive and can isolate cells without damaging them, which is important for downstream applications. Consumables can be used to isolate large numbers of cells, which is important for applications such as cell therapy and drug discovery where large quantities of cells are needed.
The human cells segment accounted for the largest share of the cell type segment in the cell isolation market in 2022.
Based on cell type, the cell isolation market is categorized into two segments—human cells and animal cells. In 2022, human cells segment accounted for the largest share of cell isolation market. Factors such as the increasing investments by public and private organizations for research on human cells are projecting the segmental growth. The use of human cells for research is regulated by various agencies, such as the FDA and the NIH. Therefore, using human cells that have been obtained from reputable sources can ensure regulatory compliance. Human cells are directly relevant to clinical applications such as regenerative medicine, tissue engineering, and cell-based therapies. This makes human cell isolation an essential part of medical research. Human cells are diverse, which allows for the study of a wide range of diseases and conditions. Human cell isolation allows researchers to isolate specific cell types for further study.
Asia Pacific is likely to grow at double digit growth rate during the forecast period.
The Asia Pacific region is estimated to grow at the highest CAGR in the cell isolation market during the forecast period, this is mainly due to the rising geriatric population and increasing number of hospitals in Asian countries. Moreover, increasing chronic diseases in the countries of this region is likely to boost the market. Also, growing infectious diseases in the region is attracting several foreign investors in the market. Governments in the APAC region are supporting research in various ways, such as funding research institutes and offering tax incentives to biotech and life sciences companies. This has led to an increased demand for cell isolation technologies to support this research.
Some of the prominent players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]